None listed
Conditions
Brief summary
ProsCan will follow men with prostate cancer from the time of diagnosis to five years post-treatment to better understand their patterns of care and the resulting impact of diagnosis and treatment on their psychosocial, physical functioning and quality of life outcomes. In addition, the genetic biomarkers of prostate cancer will be investigated with particular emphasis on the relationship between biomarkers and clinical/medical outcomes. The project will evaluate whether there are subgroups of men who have better or worse outcomes based on the analysis of psychosocial and prognostic markers. Men with localised cancer will be offered the opportunity to participate in a randomised-controlled trial evaluating a telephone-based nurse-delivered, broad reach supportive care intervention. The intervention will provide support for treatment decision-making, managing the side effects of treatment, and stress management with the goal of improving quality of life. This is one of the first Australian large-scale longitudinal studies to track men with prostate cancer from the point of diagnosis and to follow them over time, and the first study internationally to assess this type of supportive care intervention.
Interventions
The support intervention is delivered by trained Prostate Care Nurses, and is designed to work with men from the time of diagnosis through to 5 months post-treatment, to assist men to manage the challenges associated with their diagnosis and treatment. The intervention focuses on treatment decision making, coping and stress management, and after treatment care related to treatment side-effects. The intervention is manualised and supported by a range of standard patient education materials and sp
The support intervention is delivered by trained Prostate Care Nurses, and is designed to work with men from the time of diagnosis through to 5 months post-treatment, to assist men to manage the challenges associated with their diagnosis and treatment. The intervention focuses on treatment decision making, coping and stress management, and after treatment care related to treatment side-effects. The intervention is manualised and supported by a range of standard patient education materials and specifically developed resources. All participants receive a minimum of two intervention calls pre-treatment with the option for additional calls in instances where men are highly distressed or experiencing high uncertainty around treatment decision making. An additional two calls are made in the early post-treatment phase, with a booster at 5 months post-treatment. Men who are ineligible to participate in the randomised controlled trial, but who are eligible to take part in the larger epidemiological study will receive usual care from their clinician and will be provided with the standard patient education materials currently available to prostate cancer patients.
Sponsors
The Cancer Council Queensland
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Educational / counselling / training
Masking
Open (masking not used)
Eligibility
Sex/Gender
Male
Age
18 Years to -2147483648 No limit
Healthy volunteers
No
Inclusion criteria
First histological diagnosis of prostate cancer of any stage Diagnosed in Queensland Ability to give informed consent English-speaking Access to telephone. Additional inclusion criteria for the intervention component of the ProsCan project: Diagnosis of localised prostate cancer
Exclusion criteria
Cognitive impairment. Additional exclusion criteria for the intervention component of the ProsCan project: Locally advanced or metastatic prostate cancer Psychiatric illness Receiving active treatment for another cancer
Outcome results
None listed